Priming with intracervically administered prostaglandin F2 alpha before abortion
Gstöttner, H.; Richter, H.; Rothe, K.
Zentralblatt für Gynakologie 101(6): 404-408
1979
ISSN/ISBN: 0044-4197 PMID: 452760 Document Number: 142822
75 Patients were treated with Prostaglandin-F2 alpha-gel intracervical to ripe the cervix prior to first trimester abortion. In all patients we get the wanted effect with Prostaglandin-gel. Priming of the cervix seemed to be especially needed with PG-gel in young patients with first pregnancy.
Document emailed within 1 workday
Related Documents
Watanabe, K.; Iguchi, Y.; Iguchi, S.; Arai, Y.; Hayaishi, O.; Roberts, L.J. 1986: Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase Proceedings of the National Academy of Sciences of the United States of America 83(6): 1583-1587De Grandi, P.; Nguyen The, H.; Suppan, P.; Kunz, B. 1979: Prostaglandin F-2-alpha gel for induction of midtrimester abortion Journal de Gynecologie Obstetrique et Biologie de la Reproduction 8(5): 455-462
Koeffler, H.; Tervilä, L. 1974: Comparison of abortion performed with prostaglandin F2 alpha and hysterotomy Annales Chirurgiae et Gynaecologiae Fenniae 63(6): 483-486
Göretzlehner, G.; Rudolf, K.; Frahm, R. 1977: Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha Zentralblatt für Gynakologie 99(22): 1356-1360
Anderson, G.G.; Hobbins, J.C.; Rajkovic, V.; Speroff, L.; Caldwell, B.V. 1972: Midtrimester abortion using intra-amniotic prostaglandin F2 alpha with intravenous Syntocinon Journal of Reproductive Medicine 9(6): 434-436
Hørding, U. 1988: Mid-trimester therapeutic abortion by intra-amniotic prostaglandin F2 alpha and concomitant oxytocin Clinical and Experimental Obstetrics and Gynecology 15(4): 124-128
During, R.; Mauck, I.; Schwarzlos, G. 1977: Blood coagulation studies of therapeutic abortion induced by 15-methyl-prostaglandin F2 alpha Zentralblatt für Gynakologie 99(22): 1361-1365
Novak-Antolic, Z.; Assejev, V. 1982: Induction of abortion in the second trimester of pregnancy by intramuscular 15-methyl prostaglandin F 2 alpha (Prostin 15M) Clinical and Experimental Obstetrics and Gynecology 9(1): 4-6
Schulze, G.; Koinzer, G. 1978: Induced abortion using intrauterine, extra-amniotic administration of prostaglandin F2 alpha in primigravidae Zentralblatt für Gynakologie 100(19): 1272-1277
Schiff, E.; Lipitz, S.; Ben-Baruch, G.; Chetrit, A.; Oelsner, G.; Menczer, J. 1991: Midtrimester abortion induction with intraamniotic prostaglandin F2 alpha in women with previous uterine surgery Journal of Reproductive Medicine 36(3): 198-200
Manuilova, I.A.; Murashko, L.E.; Asribekova, M.K.; Goncharova, V.N. 1983: Effect of 15-me-prostaglandin F2 alpha on the release of endogenous prostaglandin F2 alpha and the concentration of estrogen and progesterone receptors in the human endometrium Akusherstvo i Ginekologiia 1: 54-55
Rajan, R.; Subhadra, N.M.; Sarada, A.K.; Usha, D.L.; John, R. 1979: Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion Journal of Obstetrics and Gynaecology of India 29(1): 38-43
Boes, E.G. 1980: Missed abortion, hydatidiform mole and intra-uterine fetal death treated with 15-methyl-prostaglandin F 2-alpha South African Medical Journal 58(22): 878-880
Rajan, R.; Subhadra, N.M.; Sarada, A.K.; Usha, D.L.; John, R. 1979: Evaluation of a lower dose schedule of intramuscular 15(S)-15-methyl prostaglandin F2 alpha for induction of early midtrimester abortion Journal of Obstetrics and Gynaecology of India 29(1): 38-43
Grimes, D.A.; Cates, W. 1979: The comparative efficacy and safety of intraamniotic prostaglandin F2 alpha and hypertonic saline for second-trimester abortion. a review and critique Journal of Reproductive Medicine 22(5): 248-254
Kerekes, L.; Domokos, N. 1975: Labor induction with prostaglandin F2-alpha and oxytocin, accompanied by membrane rupturing as well as supportive prostaglandin F2-alpha therapy (comparative study) Orvosi Hetilap 116(48): 2833-2836
Stinger, R.B.; Fitzpatrick, T.M.; Corey, E.J.; Ramwell, P.W.; Rose, J.C.; Kot, P.A. 1982: Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha Journal of Pharmacology and Experimental Therapeutics 220(3): 521-525
Høgdall, E.V.; Høgdall, C.K. 1991: 15(S)-15-methyl-prostaglandin F2 alpha. a potent synthetic prostaglandin F2 alpha for treatment of postpartum atony Ugeskrift for Laeger 153(46): 3260-3262
Roux, C.J.; Odendaal, H.J. 1981: Continuous monitoring of uterine contractions to control intra-amniotic administration of prostaglandin F2 alpha for therapeutic and missed abortion South African Medical Journal 59(23): 819-821
Lindmark, G.; Nilsson, B.A.; Nyberg, R.; Zador, G. 1973: Induction of abortion with prostaglandin F2 alpha. Intravenous, extra-amniotic and intra-amniotic administration Lakartidningen 70(44): 3939-3943